Nebulisable liposomes – Method for the pulmonary delivery of agents
The treatment of lung and respiratory diseases, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), pneumonia and pulmonary hypertension, is carried out by means of agents with a long biological half-life. Liposomes are favoured that remain as stable as possible during nebulisation and that achieve a delayed release of the agent with as few side-effects as possible.
The liposome formulations at hand fulfil these requirements of the delivery of pharmaceutical agents to the lung in an outstanding manner. They are characterised by a good tolerance, because they are composed out of the body's own substances that are found naturally in the lung. The composition of liposomes is selected in such a way that the agents packed therein are released selectively and over a specific period of time, in a controlled manner.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
